Glucose, Serum 86 mg/dL 65 − 99 01
BUN 23 mg/dL 6 − 24 01
Creatinine, Serum 1.11 mg/dL 0.76 − 1.27 01
eGFR If NonAfricn Am 83 mL/min/1.73 >59
eGFR If Africn Am 96 mL/min/1.73 >59
BUN/Creatinine Ratio 21 High 9 − 20
Sodium, Serum 136 mmol/L 134 − 144 01
Potassium, Serum 4.1 mmol/L 3.5 − 5.2 01
Chloride, Serum 94 Low mmol/L 97 − 108 01
Carbon Dioxide, Total 22 mmol/L 20 − 32 01
Calcium, Serum 9.2 mg/dL 8.7 − 10.2 01
Protein, Total, Serum 7.5 g/dL 6.0 − 8.5 01
Albumin, Serum 4.5 g/dL 3.5 − 5.5 01
Globulin, Total 3.0 g/dL 1.5 − 4.5
A/G Ratio 1.5 1.1 − 2.5
Bilirubin, Total 0.5 mg/dL 0.0 − 1.2 01
Alkaline Phosphatase, S 83 IU/L 25 − 150 01
AST (SGOT) 32 IU/L 0 − 40 01
ALT (SGPT) 28 IU/L 0 − 44 01
**Please note reference interval change**
. 01
Lipids 01
Cholesterol, Total 178 mg/dL 100 − 199 01
Triglycerides 96 mg/dL 0 − 149 01
HDL Cholesterol 64 mg/dL >39 01
Comment 01
According to ATP−III Guidelines, HDL−C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 19 mg/dL 5 − 40
LDL Cholesterol Calc 95 mg/dL 0 − 99
LDL/HDL Ratio 1.5 ratio units 0.0 − 3.6
Phone: 713−856−8288
Account Number
Specimen Number
Thyroid 01
TSH 1.800 uIU/mL 0.450 − 4.500 01
Thyroxine (T4) 9.6 ug/dL 4.5 − 12.0 01
Triiodothyronine,Free,Serum 3.2 pg/mL 2.0 − 4.4 01
T4,Free(Direct) 1.34 ng/dL 0.82 − 1.77 01
. 01
Immunoassay 01
Prostate Specific Ag, Serum 0.8 ng/mL 0.0 − 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Insulin−Like Growth Factor I 149 ng/mL 69 − 226 02
Testosterone, Serum 137 Low ng/dL 348 − 1197 01
Free Testosterone(Direct) 5.9 Low pg/mL 6.8 − 21.5 02
LH 15.8 High mIU/mL 1.7 − 8.6 01
Estradiol 22.2 pg/mL 7.6 − 42.6 01
Roche ECLIA methodology
Insulin 16.5 uIU/mL 2.6 − 24.9 01
. 01
CBC, Platelet Ct, and Diff 01
WBC 7.2 x10E3/uL 4.0 − 10.5 01
RBC 4.85 x10E6/uL 4.14 − 5.80 01
Hemoglobin 14.5 g/dL 12.6 − 17.7 01
Hematocrit 43.4 % 37.5 − 51.0 01
MCV 90 fL 79 − 97 01
MCH 29.9 pg 26.6 − 33.0 01
MCHC 33.4 g/dL 31.5 − 35.7 01
RDW 14.5 % 12.3 − 15.4 01
Platelets 252 x10E3/uL 140 − 415 01
Neutrophils 56 % 40 − 74 01
Lymphs 33 % 14 − 46 01
Monocytes 10 % 4 − 13 01
Eos 1 % 0 − 7 01
Basos 0 % 0 − 3 01
Neutrophils (Absolute) 4.0 x10E3/uL 1.8 − 7.8 01
Lymphs (Absolute) 2.4 x10E3/uL 0.7 − 4.5 01
Monocytes(Absolute) 0.7 x10E3/uL 0.1 − 1.0 01
Eos (Absolute) 0.1 x10E3/uL 0.0 − 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 − 0.2 01
JZ